vimarsana.com

/PRNewswire/ -- The board of directors for Hansa Biopharma AB (publ) has today resolved to issue 850,769 new class C shares and to immediately thereafter...

Related Keywords

Sweden ,Hansa Biopharma ,Klaus Sindahl ,Share Rights Program ,Rights Program ,Adoption Program ,Outstanding Incentive ,Hansa Biopharma Ab ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Accounting News Amp Issues ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.